PHF5A has been described to act as a promising cancer stem cell (CSCs) biomarker/prognosticator predicting the prognosis of cancer stem cells in a patient with oral carcinomas i.e. squamous cell carcinoma. This evidence concerns the gene PHF5A and cancer.